Page 4 - Erik Manting News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Mendus to present at Cell & Gene Therapy Manufacturing & Commercialization Conference in Dublin on December 4-6

Press Release Stockholm, Sweden, December 5, 2023 Mendus AB , a biopharmaceutical company focused on immunotherapies addressing tumor recurrence, today announced it will present the.

United statesErik mantingLeopold berteaAmerican society of hematologyGene therapy manufacturingCommercialization conferenceChief technology officer leopold berteaCell therapy manufacturingNorthx biologicsRobust industrial manufacturing processCancer maintenance treatmentNasdaq stockholmAmerican societyOrphan drug designationFast track designation

Mendus to Host KOL Event to Review Phase 2 Data with Vididencel in Acute Myeloid Leukemia Presented at ASH 2023 on December 14, 2023

Mendus to Host KOL Event to Review Phase 2 Data with Vididencel in Acute Myeloid Leukemia Presented at ASH 2023 on December 14, 2023
finanzen.at - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanzen.at Daily Mail and Mail on Sunday newspapers.

United statesNoord hollandErik mantingVu university medical centerDepartment of internal medicineGroningen university medical centerDutch society of cytometryAmerican society of hematologyPrincipal investigatorAcute myeloid leukemiaAmerican societyAnnual meetingMedical schoolMedical centerInternal medicineDendritic cell

NOTICE OF EXTRAORDINARY GENERAL MEETING IN MENDUS AB (PUBL)

Press Release Stockholm, Sweden, November 13, 2023 The shareholders of Mendus AB , reg. no 556629-1786, are hereby invited to the Extraordinary General Meeting on Wednesday, 13.

City ofUnited kingdomHans preustingChristine lindDharminder chahalAndrea van elsasErik mantingSynerkine pharmaSven andreassonArticles of associationEmployee stock option programSwedish companiesSwedish companies registration officeEuropean parliamentTekiu ltdCompany the participants

Mendus presents updated ALISON clinical trial data for vididencel in ovarian cancer at SITC 2023

Mendus presents updated ALISON clinical trial data for vididencel in ovarian cancer at SITC 2023
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesErik mantingAmerican society of hematologySociety for immunotherapy of cancerAnnual meetingJeroen roversChief medical officerNasdaq stockholmAmerican societyOrphan drug designationFast track designationNorthx biologics

Mendus Phase 1 vididencel clinical trial results in AML and high-risk MDS patients published in peer-reviewed medical journal

Press Release Stockholm, Sweden, November 3, 2023 Mendus Phase 1 vididencel clinical trial results in AML and high-risk MDS patients published in peer-reviewed medical journal Publication.

Noord hollandUnited statesErik mantingCancer center amsterdamAmerican society of hematologyErasmus university medical centerHigh risk myelodysplastic syndromeAcute myeloid leukemia patients receivingPrincipal investigatorJeroen roversChief medical officerNasdaq stockholmAmerican societyOrphan drug designationFast track designationNorthx biologics